CORE is a 36-month EU Action Grant running from January 1st 2023 to December 31st 2025 and involves 24 partners from 16 EU Member States. The project aims to reduce inequalities in the HIV, TB and viral hepatitis responses by promoting, strengthening and integrating the community responses that have proven key in reaching communities traditionally underserved by mainstream prevention and healthcare services. This approach is particularly vital in the context of countries where these responses are still inadequate compared to the EU average.
CORE is co-funded by the EU4Health Programme 2021 – 2027.
DRUG-PREP aims to contribute to enhanced preparedness and resilience of EU countries’ drug surveillance systems and effective policy making. The overall aim of DRUG-PREP is to contribute to better insight and understanding of current and future trends and developments to support greater preparedness and resilience of health systems of countries in Europe by strengthening effective assessment and response systems.
The project combines qualitative and participatory research, multi-stakeholder capacity building and networking performed by 7 project partners: the Trimbos Institute (NL), Sciensano (BE), National Institute for Health and Wellbeing (FI), SICAD (PT), the Health Research Board of Ireland’s Department of Health (IE), the Office of the Government of the Czech Republic (CZ), and Correlation – European Harm Reduction Network (NL).
The Civil Society Forum on Drugs (CSFD) is an expert group of the European Commission that was created in 2007 on the basis of the Commission Green Paper on the role of civil society in drugs policy in the EU.
The general objective of this project was to enhance the implementation of Quality Standards in drug prevention, treatment and harm reduction throughout the EU, with more services, organisations and countries applying QS in daily practice. The project focused on applying QS in all EU countries and factors stimulating implementation.
The project focused on the actual application of quality standards and factors stimulating/hindering implementation. By identifying good practice examples and successful implementation models and strategies, the goal was to provide access to key stakeholders (e.g. policymakers, service providers, end users) to dos and don’ts for implementing quality standards in various areas of Drug Demand Reduction. An implementation toolkit has been developed and field-tested, tailored to specific groups of stakeholders and presented in an accessible and comprehensible way to guarantee optimal utilization. Country representatives and civil society organizations were involved throughout the project to maximize these stakeholders’ ability to share examples of good practices and to implement the project’s recommendations in daily practice and at a local level.
The project started in April 2021 and was led by the University of Gent, Belgium.
Partners: Ghent University, Charles University, University of Zagreb, Claude Bernard University of Lyon, IREFREA Network, C-EHRN, EUFAS, Euro-TC.
The European Network of Drug Consumption Rooms [ENDCR] is a membership-based civil society platform uniting organisations operating or planning to implement a Drug Consumption Room [DCR] in Europe. Its goal is to enhance the availability, accessibility and quality of these services. Hosted and coordinated by Correlation – European Harm Reduction Network [C-EHRN] , the ENDCR is governed by a Core Group and channels its activities through various thematic Work Groups.
The Nobody Left Outside (NLO) initiative is a collective of organisations representing people in some of the most marginalised communities in Europe, who are underserved with respect to healthcare. These communities include homeless people, LGTBI people, people who use drugs, prisoners, sex workers and undocumented migrants. The initiative provides a European-level platform for organizations to collaborate to identify shared challenges, exchange lessons and good practices, seek innovative solutions, and speak with a collective voice to offer guidance to improve healthcare access for the communities of people they work with and for.
Participant organisations: Africa Advocacy, C-EHRN, European AIDS Treatment Group, FEANTSA, Hepatitis C Trust, ICRSE, ILGA-Europe, ISGlobal, NPS Italia Onlus, PICUM.
The aim of the SO-PREP project is to contribute to the enhancement of SO-PREParedness of the European Member States to effectively monitor and respond to SO-related health risks, hazards and harms.
Monitoring and evaluating policy implementation by civil society organisations are crucial for ensuring government accountability. Such independent evaluations not only enhance current services and programmes for people who use drugs but also enrich knowledge and support advocacy and policy-making through insights from local service providers. This is a key goal of the C-EHRN monitoring efforts.
Since the Monitoring's inception in 2018, C-EHRN has published annual reports, relying on its network of Focal Points (FPs) for data collection. This data is gathered directly from harm reduction service providers and indirectly from service clients at the grassroots level. The focus has been on city-level data since 2020.
